NCT05403294

Brief Summary

Obesity is associated with a number of risk factors for cardiovascular disease. Body mass index (BMI) is the most commonly recommended and used anthropometric measure to classify general obesity in clinical and epidemiological studies. It is widely accepted that obesity increases the risk of heart disease and is thought to be a risk factor for adverse outcomes after cardiac surgery. However, recent studies show paradoxical results, wherein obese patients can experience fewer adverse events and lower mortality than patients with normal-low body mass index(BMI) . The discriminative capacity of BMI has been criticized because it cannot distinguish muscle mass from fat mass, or reflect fat distribution . Alternatively, abdominal obesity indices, such as waist circumference (WC) and waist-to-height ratio (WHtR), have been suggested to be better predictor of cardiometabolic abnormalities because they modulate the limitation of BMI. However, they were insufficient in studies.For this reason, scientists turned to find a new anthropometric formula that could better detect obesity-related mortality and morbidity and they developed 2 new methods. Body Shape İndex (ABSI) is calculated using waist circumference, BMI and height parameters. Body Roundness İndex (BRI) is calculated using waist circumference and height parameters. These new indices may reflect visceral adiposity and strongly predict cardiovascular risk, postsurgical outcomes and resource utilisation.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
240

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2022

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 2, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 3, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

July 27, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2022

Completed
Last Updated

July 28, 2022

Status Verified

July 1, 2022

Enrollment Period

2 months

First QC Date

May 2, 2022

Last Update Submit

July 26, 2022

Conditions

Outcome Measures

Primary Outcomes (5)

  • mortality

    Number of death at 30 days after surgery

    within 30 days of the procedure

  • postoperative stroke

    Number of patients with postoperative stroke

    within 30 days of the procedure

  • cardiac arrest

    number of patients with cardiac arrest

    within 30 days of the procedure

  • new atrial fibrillation/flutter

    Number of Partients with new atrial fibrillation/flutter

    within 30 days of the procedure

  • permanent rhythm device insertion

    Number of Patients requiring insertion of a permanent device

    within 30 days of the procedure

Secondary Outcomes (6)

  • prolonged ventilation

    within 30 days of the procedure

  • sepsis /deep sternal infection

    within 30 days of the procedure

  • pulmonary complications

    within 30 days of the procedure

  • renal failure / renal dialysis

    within 30 days of the procedure

  • total intensive care unit (ICU) hours

    within 30 days of the procedure

  • +1 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients over the age of 18 who have undergone open heart surgery

You may qualify if:

  • open heart surgery
  • voluntary patients

You may not qualify if:

  • emergency surgery
  • off-pump or robotic surgery
  • surgery requiring deep hypothermic circulatory arrest
  • reluctant patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 2, 2022

First Posted

June 3, 2022

Study Start

July 27, 2022

Primary Completion

October 1, 2022

Study Completion

November 1, 2022

Last Updated

July 28, 2022

Record last verified: 2022-07